Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dexcel Pharma Technologies Ltd. Insider Profile
4 Followers
Dexcel Pharma Technologies Ltd., Ten Percent Owner at Arbutus Biopharma, holds 4.23M shares in Intec Pharma (Ticker: NTEC), holds 16.01M shares in Arbutus Biopharma (Ticker: ABUS). Most recently, Dexcel Pharma Technologies Ltd. Sold ― shares of Intec Pharma on Feb 04, 2020 for an estimated value of 274.49K.
Dexcel Pharma Technologies Ltd. Arbutus Biopharma (ABUS)Ten Percent Owner
Arbutus Biopharma (ABUS)
Ten Percent Owner
Ranked #37,626 out of 78,624 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+4.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dexcel Pharma Technologies Ltd. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd.'s Trading History
Arbutus Biopharma
Oct 18, 2017
Ten Percent Owner
Informative Buy
―
$69.50M
Intec Pharma
Feb 04, 2020
Ten Percent Owner
Informative Sell
274.49K
$13.76M
List of latest transactions for each holding click on a transaction to see Dexcel Pharma Technologies Ltd.'s performance on stock
You May Also Like
Dexcel Pharma Technologies Ltd. insider profile FAQ
What is the percentage of profitable transactions made by Dexcel Pharma Technologies Ltd.?
The percentage of profitable transactions made by Dexcel Pharma Technologies Ltd. is 50%.
What is the average return per transaction made by Dexcel Pharma Technologies Ltd.?
The average return per transaction made by Dexcel Pharma Technologies Ltd. is 4.20%.
What stocks does Dexcel Pharma Technologies Ltd. hold?
Dexcel Pharma Technologies Ltd. holds: ABUS, NTEC stocks.
What was Dexcel Pharma Technologies Ltd.’s latest transaction?
Dexcel Pharma Technologies Ltd. latest transaction was an Informative Sell of $274.49K.
What was Dexcel Pharma Technologies Ltd.'s most profitable transaction?
Dexcel Pharma Technologies Ltd.’s most profitable transaction was an Informative Sell of NTEC stock on February 4, 2020. The return on the trade was 41.70%.
What is Dexcel Pharma Technologies Ltd.'s role in Arbutus Biopharma?
Dexcel Pharma Technologies Ltd.'s role in Arbutus Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.